| Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC) | 
| Synonyms- | 
| Target | 
| Action modulators | 
| Mechanism CCKB modulators(Cholecystokinin B receptor modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Thyroid Cancer, Medullary | Phase 1 | China  | 21 Jun 2023 | 





